Evidence map›Paper›PMID 32166376›Full record

ArticleArchives of dermatological research2020

Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.

Peter Theut Riis, Ditte Marie Saunte, Viktoria Sigsgaard, Axel Patrice Villani, Philippe Guillem, José C Pascual, Naomi N Kappe, Annika M J D Vanlaerhoven, Hessel H van der Zee, Errol P Prens and 31 more

Open access · bronzeAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 16 countries.

Peter Theut RiisDepartment of Dermatology, Zealand University Hospital, Sygehusvej 5, 4000, Roskilde, Denmark. pmik@regionsjaelland.dk.
Ditte Marie SaunteDepartment of Dermatology, Zealand University Hospital, Sygehusvej 5, 4000, Roskilde, Denmark.
Viktoria SigsgaardDepartment of Dermatology, Zealand University Hospital, Sygehusvej 5, 4000, Roskilde, Denmark.
Axel Patrice VillaniDermatology Department, Edouard Herriot Hospital, Claude Bernard Lyon I University, Lyon, France.
Philippe GuillemDermatology Department, Edouard Herriot Hospital, Claude Bernard Lyon I University, Lyon, France.
José C PascualDepartment of Dermatology, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain.
Naomi N KappeDepartment of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands.
Annika M J D VanlaerhovenDepartment of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands.
Hessel H van der ZeeDepartment of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands.
Errol P PrensDepartment of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands.
Moetaz El-DomyatiDepartment of Dermatology, Minia University, Al-Minya, Egypt.
Hossam Abdel-WahabDepartment of Dermatology, Minia University, Al-Minya, Egypt.
Nayera MoftahDepartment of Dermatology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Rania AbdelghaniDepartment of Dermatology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Eugenia Agut-BusquetHospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Jorge RomaníDepartment of Dermatology, Hospital Parc Tauli in Sabadell, Autonomous University of Barcelona (UAB), Barcelona, Spain.
Carol HlelaDepartment of Dermatology, Red Cross Children's Hospital, University of Cape Town, Cape Town, South Africa.
Lerinza van den WormDepartment of Dermatology, Red Cross Children's Hospital, University of Cape Town, Cape Town, South Africa.
Vincenzo BettoliDepartment of Medical Sciences, O.U. of Dermatology, Azienda Ospedaliera-University of Ferrara, Cona, Italy.
Giada CalamoDepartment of Medical Sciences, O.U. of Dermatology, Azienda Ospedaliera-University of Ferrara, Cona, Italy.
Mehmet Ali GürerDepartment of Dermatology, Gazi University, Faculty of Medicine, Ankara, Turkey.
Burcu BeksaçDepartment of Dermatology, Gazi University, Faculty of Medicine, Ankara, Turkey.
Lukasz MatusiakDepartment of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Amelia GlowaczewskaDepartment of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Jacek C SzepietowskiDepartment of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Lennart EmtestamUnit of Infection and Dermatology, Department of Medicine, Huddinge at Karolinska Institutet, Stockholm, Sweden.
Jan LapinsUnit of Infection and Dermatology, Department of Medicine, Huddinge at Karolinska Institutet, Stockholm, Sweden.
Hassan Riad KottbHamad Medical Corporation, Doha, Qatar.
Mohammad FataniDepartment of Dermatology, Hera General Hospital, Makkah, Saudi Arabia.
Lisa WeibelDepartment of Pediatric Dermatology, University Children's Hospital Zurich, Zurich, Switzerland.
Martin TheilerDepartment of Pediatric Dermatology, University Children's Hospital Zurich, Zurich, Switzerland.
Maïa Delage-TorielCentre Médical de L'Institut Pasteur, Paris, France.
Thi Thanh Hong LamCentre Médical de L'Institut Pasteur, Paris, France.
Aude NassifCentre Médical de L'Institut Pasteur, Paris, France.
Pierre-Andre BecherelHôpital Privé D'Antony, Antony, France.
Mateja Dolenc-VoljcDepartment of Dermatovenereology, University Medical Centre Ljubljana; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Nejib DossDepartment of Dermatology, Hôpital Militaire, Tunis, Tunisia.
Dorra BouazziDepartment of Dermatology, Zealand University Hospital, Sygehusvej 5, 4000, Roskilde, Denmark.
Farida BenhadouDepartment of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Veronique Del MarmolDepartment of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Gregor B E JemecDepartment of Dermatology, Zealand University Hospital, Sygehusvej 5, 4000, Roskilde, Denmark.
Erasmus MC · NLInstitut Pasteur · FRWroclaw Medical University · PLZealand University Hospital · DKGazi University · TRKarolinska Institutet · SEMinia University · EGUniversité Claude Bernard Lyon 1 · FRUniversité Libre de Bruxelles · BEUniversity of Cape Town · ZAUniversity of Copenhagen · DKUniversity of Ferrara · ITAl-Azhar University · EGArmed Forces College of Medicine · EGDeleted InstitutionFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHamad Medical Corporation · QAHera General Hospital · SAMilitary Hospital of Tunis · TNUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hidradenitis suppurativa (HS) rarely affects pediatric patients. The literature on pediatric HS patients is scarce. This is a cross-sectional study based on case note review or interviews and clinical examination of 140 pediatric patients undergoing secondary or tertiary level care. Patients were predominantly female (75.5%, n = 105) with a median age of 16. 39% reported 1st-degree relative with HS. Median BMI percentile was 88, and 11% were smokers (n = 15). Median modified Sartorius score was 8.5. Notable comorbidities found were acne (32.8%, n = 45), hirsutism (19.3%, n = 27), and pilonidal cysts (16.4%, n = 23). Resorcinol (n = 27) and clindamycin (n = 25) were the most frequently used topical treatments. Patients were treated with tetracycline (n = 32), or oral clindamycin and rifampicin in combination (n = 29). Surgical excision was performed in 18 patients, deroofing in five and incision in seven patients. Obesity seemed to be prominent in the pediatric population and correlated to parent BMI, suggesting a potential for preventive measures for the family. Disease management appeared to be similar to that of adult HS, bearing in mind that the younger the patient, the milder the disease in majority of cases.

Indexed as

Dermatologic Surgical ProceduresAcne VulgarisAdministration, CutaneousAdministration, OralAdolescentAnti-Bacterial AgentsBody Mass IndexChildClindamycinComorbidityCross-Sectional StudiesDrug Therapy, CombinationFemaleHidradenitis SuppurativaHirsutismHumansAnti-Bacterial AgentsClindamycinresorcinolResorcinolsRifampinTetracyclineAcne inversaChildrenHidradenitis suppurativaPediatric

Identifiers

PMID32166376
OpenAlexW3010808930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.